The Series B Pipeline Looks Refreshingly Diversified

· Source: Artificial intelligence - Crunchbase News · Field: Finance & Economics — Capital Markets & Investment Management, Economic Analysis & Policy · Depth: Intermediate, quick

Summary

U.S. Series B investment trends reveal a diversified funding landscape, contrary to assumptions of AI sector dominance. While AI remains a leading theme, significant rounds span biotech, robotics, and security. Annual Series B funding has steadily increased since a 2023 low, with 2024 showing a strong start. Round counts are stable, indicating no dramatic capital concentration at this stage. Notable investments include a $2 billion Nvidia-led round for Reflection AI, a $600 million round for Kailera Therapeutics in obesity treatments, and another $600 million for AI robotics startup Physical Intelligence. Average Series B round sizes are also growing, reaching a record $68 million in 2026, though smaller rounds ($1M-$10M) have become scarcer, dropping from around 150 annually to 44 last year. Healthcare and biotech received over a quarter of recent Series B funding, with robotics and hardware accounting for about 15%.

Key takeaway

For entrepreneurs seeking Series B funding, recognize that while AI is prominent, investors are actively diversifying across sectors like biotech and robotics. Your pitch should emphasize a proven technological edge or early market traction, as investors at this stage are making less risky bets. Be aware that average round sizes are increasing, but smaller Series B rounds are becoming less common, so target a substantial raise.

Key insights

Series B funding shows diversification beyond AI, increasing average round sizes, and stable round counts.

Principles

In practice

Topics

Best for: Investor, Entrepreneur, Business Analyst

Related on AIssential

Open in AIssential →

Editorial summary, takeaway, and curation by AIssential. Original article published by Artificial intelligence - Crunchbase News.